WebFeb 23, 2024 · Roche Holding AG has agreed to buy Philadelphia biotechnology company Spark Therapeutics Inc., as the Swiss drugmaker seeks to expand its presence treating … WebOct 25, 2024 · Roche's acquisition of Spark Therapeutics will likely close before the year ends, an analyst said after reports suggested U.S. regulators would bless the deal.. X. Late …
Why Roche
WebMar 4, 2024 · If Spark gene therapy is successful, Roche's acquisition of Spark can be more competitive in the hemophilia treatment market. As an emerging category of Roche, hemophilia will be the best boost to growth in its market. In 2014, Pfizer worked with Spark Therapeutics to develop hemophilia gene therapy. WebDec 17, 2024 · The Federal Trade Commission and European regulators cleared Roche's proposed $4.3 billion purchase of Spark Therapeutics, paving the way for its acquisition of the Philadelphia gene therapy... props inn new hartford ny
The Wait Is Over: After Multiple Delays, Roche Completes
WebThe company is currently developing several gene therapies to target a suite of diseases, including Haemophilia A and B, and several central nervous system diseases. In December 2024, the company was acquired by Hoffmann-La Roche for $4.3 billion. [6] [7] It now continues to operate as an independent subsidiary. [8] WebFeb 25, 2024 · Roche is acquiring Spark Therapeutics in a multi-billion dollar deal that underscores big pharma's growing appetite for new technologies like gene therapy. Spark, which secured the first ever U.S. approval for a gene therapy targeting an inherited disease, will sell for $114.50 per share — a roughly 120% premium to its closing price on Feb. 22. WebDec 17, 2024 · Dec 17 (Reuters) - Roche Holding AG: * ROCHE CONCLUDES ACQUISITION OF SPARK THERAPEUTICS, INC. TO STRENGTHEN PRESENCE IN GENE THERAPY. * ROCHE, SPARK THERAPEUTICS ANNOUNCE COMPLETION OF ... props inn new hartford